Click here to get full coverage on Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year? - Yahoo Finance

Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year?  Yahoo Finance

Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year? - Yahoo Finance

Click here to get full coverage on A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation Following Recent Share Price Gains - simplywall.st

A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation Following Recent Share Price Gains  simplywall.st

A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation Following Recent Share Price Gains - simplywall.st

Click here to get full coverage on New Analyst Forecast: $AUPH Given $16 Price Target - Quiver Quantitative

New Analyst Forecast: $AUPH Given $16 Price Target  Quiver Quantitative

New Analyst Forecast: $AUPH Given $16 Price Target - Quiver Quantitative

Click here to get full coverage on What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now? - Yahoo Finance

What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now?  Yahoo Finance

What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Click here to get full coverage on Aruinia stock gains after Q3 earnings beat (AUPH:NASDAQ) - Seeking Alpha

Aruinia stock gains after Q3 earnings beat (AUPH:NASDAQ)  Seeking Alpha

Aruinia stock gains after Q3 earnings beat (AUPH:NASDAQ) - Seeking Alpha

Click here to get full coverage on Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified - simplywall.st

Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified  simplywall.st

Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified - simplywall.st

Click here to get full coverage on Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates?  Yahoo Finance

Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Yahoo Finance

Click here to get full coverage on Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH) - Seeking Alpha

Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH)  Seeking Alpha

Aurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade) (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on $AUPH stock is down 18% today. Here's what we see in our data. - Quiver Quantitative

$AUPH stock is down 18% today. Here's what we see in our data.  Quiver Quantitative

$AUPH stock is down 18% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Is Up 9.1% After Upgraded 2025 Revenue Guidance and Strong Q3 Earnings – Has The Bull Case Changed? - simplywall.st

Aurinia Pharmaceuticals (AUPH) Is Up 9.1% After Upgraded 2025 Revenue Guidance and Strong Q3 Earnings – Has The Bull Case Changed?  simplywall.st

Aurinia Pharmaceuticals (AUPH) Is Up 9.1% After Upgraded 2025 Revenue Guidance and Strong Q3 Earnings – Has The Bull Case Changed? - simplywall.st

Click here to get full coverage on Aurinia responds after top FDA official’s comment on lead drug - Seeking Alpha

Aurinia responds after top FDA official’s comment on lead drug  Seeking Alpha

Aurinia responds after top FDA official’s comment on lead drug - Seeking Alpha

Click here to get full coverage on Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year?  Yahoo Finance

Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Click here to get full coverage on Are Strong Financial Prospects The Force That Is Driving The Momentum In Aurinia Pharmaceuticals Inc.'s NASDAQ:AUPH) Stock? - simplywall.st

Are Strong Financial Prospects The Force That Is Driving The Momentum In Aurinia Pharmaceuticals Inc.'s NASDAQ:AUPH) Stock?  simplywall.st

Are Strong Financial Prospects The Force That Is Driving The Momentum In Aurinia Pharmaceuticals Inc.'s NASDAQ:AUPH) Stock? - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH): Profitability Flips, Outpacing Market Growth Expectations and Reinforcing Bullish Narratives - simplywall.st

Aurinia Pharmaceuticals (AUPH): Profitability Flips, Outpacing Market Growth Expectations and Reinforcing Bullish Narratives  simplywall.st

Aurinia Pharmaceuticals (AUPH): Profitability Flips, Outpacing Market Growth Expectations and Reinforcing Bullish Narratives - simplywall.st

Click here to get full coverage on With 51% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance

With 51% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns  Yahoo Finance

With 51% institutional ownership, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a favorite amongst the big guns - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Profitability Milestone Reinforces Bullish Growth and Valuation Narratives - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Profitability Milestone Reinforces Bullish Growth and Valuation Narratives  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Profitability Milestone Reinforces Bullish Growth and Valuation Narratives - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Q2 Earnings Miss Estimates - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Q2 Earnings Miss Estimates  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Q2 Earnings Miss Estimates - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March - Yahoo Finance

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March  Yahoo Finance

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March - Yahoo Finance

Click here to get full coverage on Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 50%, as stock drops 5.0% this past week - simplywall.st

Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 50%, as stock drops 5.0% this past week  simplywall.st

Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 50%, as stock drops 5.0% this past week - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025 - Business Wire

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025  Business Wire

Aurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025 - Business Wire

Click here to get full coverage on The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH) - Seeking Alpha

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH)  Seeking Alpha

The Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides Opportunity (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now? - Yahoo Finance

Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now?  Yahoo Finance

Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now? - Yahoo Finance

Click here to get full coverage on Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - Yahoo Finance

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake?  Yahoo Finance

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating - Seeking Alpha

Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating  Seeking Alpha

Aurinia Pharmaceuticals: Lupkynis Growth And AUR200 Pipeline Justify Buy Rating - Seeking Alpha

Click here to get full coverage on Insider Purchase: Director at $AUPH Buys 1,000,000 Shares - Quiver Quantitative

Insider Purchase: Director at $AUPH Buys 1,000,000 Shares  Quiver Quantitative

Insider Purchase: Director at $AUPH Buys 1,000,000 Shares - Quiver Quantitative

Click here to get full coverage on Earnings Beat: Will AUPH stock attract more institutional investors - Weekly Stock Summary & Community Verified Trade Signals - moha.gov.vn

Earnings Beat: Will AUPH stock attract more institutional investors - Weekly Stock Summary & Community Verified Trade Signals  moha.gov.vn

Earnings Beat: Will AUPH stock attract more institutional investors - Weekly Stock Summary & Community Verified Trade Signals - moha.gov.vn

Click here to get full coverage on Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 - Business Wire

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025  Business Wire

Aurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025 - Business Wire

Click here to get full coverage on Aurinia Pharmaceuticals (NASDAQ:AUPH) Lowered to Hold Rating by Leerink Partnrs - MarketBeat

Aurinia Pharmaceuticals (NASDAQ:AUPH) Lowered to Hold Rating by Leerink Partnrs  MarketBeat

Aurinia Pharmaceuticals (NASDAQ:AUPH) Lowered to Hold Rating by Leerink Partnrs - MarketBeat

Click here to get full coverage on Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High - Here's Why - MarketBeat

Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High - Here's Why  MarketBeat

Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High - Here's Why - MarketBeat

Click here to get full coverage on Virtus Investment Advisers LLC Has $457,000 Stake in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Virtus Investment Advisers LLC Has $457,000 Stake in Aurinia Pharmaceuticals Inc $AUPH  MarketBeat

Virtus Investment Advisers LLC Has $457,000 Stake in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Click here to get full coverage on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Rating of "Hold" from Analysts  MarketBeat

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Click here to get full coverage on Leerink Partners Downgrades Aurinia Pharmaceuticals(AUPH.US) to Hold Rating, Raises Target Price to $16 - 富途牛牛

Leerink Partners Downgrades Aurinia Pharmaceuticals(AUPH.US) to Hold Rating, Raises Target Price to $16  富途牛牛

Leerink Partners Downgrades Aurinia Pharmaceuticals(AUPH.US) to Hold Rating, Raises Target Price to $16 - 富途牛牛

Click here to get full coverage on Aurinia Responds to Now Retracted LinkedIn Post - Business Wire

Aurinia Responds to Now Retracted LinkedIn Post  Business Wire

Aurinia Responds to Now Retracted LinkedIn Post - Business Wire

Click here to get full coverage on Aurinia Pharmaceuticals stock hits 52-week high at $16.20 - Investing.com

Aurinia Pharmaceuticals stock hits 52-week high at $16.20  Investing.com

Aurinia Pharmaceuticals stock hits 52-week high at $16.20 - Investing.com

Click here to get full coverage on Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Have Earned a 51% CAGR Over the Last Three Years - 富途牛牛

Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Have Earned a 51% CAGR Over the Last Three Years  富途牛牛

Aurinia Pharmaceuticals (NASDAQ:AUPH) Shareholders Have Earned a 51% CAGR Over the Last Three Years - 富途牛牛

Click here to get full coverage on (AUPH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

(AUPH) and the Role of Price-Sensitive Allocations  news.stocktradersdaily.com

(AUPH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Click here to get full coverage on First Week of AUPH July 2026 Options Trading - Nasdaq

First Week of AUPH July 2026 Options Trading  Nasdaq

First Week of AUPH July 2026 Options Trading - Nasdaq

Click here to get full coverage on Aurinia Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st

Aurinia Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year  simplywall.st

Aurinia Pharmaceuticals Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year - simplywall.st

Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year  simplywall.st

Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year - simplywall.st

Click here to get full coverage on Wall Street Breakfast Podcast: FDA Executive Controversy (undefined:AUPH) - Seeking Alpha

Wall Street Breakfast Podcast: FDA Executive Controversy (undefined:AUPH)  Seeking Alpha

Wall Street Breakfast Podcast: FDA Executive Controversy (undefined:AUPH) - Seeking Alpha

Click here to get full coverage on Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth (NASDAQ:AUPH) - Seeking Alpha

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth (NASDAQ:AUPH)  Seeking Alpha

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on Advantage Alpha Capital Partners LP Takes $204,000 Position in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Advantage Alpha Capital Partners LP Takes $204,000 Position in Aurinia Pharmaceuticals Inc $AUPH  MarketBeat

Advantage Alpha Capital Partners LP Takes $204,000 Position in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Click here to get full coverage on Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - TradingView

Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options  TradingView

Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - TradingView

Click here to get full coverage on Segall Bryant & Hamill LLC Sells 221,933 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Segall Bryant & Hamill LLC Sells 221,933 Shares of Aurinia Pharmaceuticals Inc $AUPH  MarketBeat

Segall Bryant & Hamill LLC Sells 221,933 Shares of Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Click here to get full coverage on FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - Stocktwits

FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’  Stocktwits

FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ - Stocktwits

Click here to get full coverage on Aurinia Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aurinia Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations  Yahoo Finance

Aurinia Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Click here to get full coverage on retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week - simplywall.st

retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week  simplywall.st

retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Yahoo Finance

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress  Yahoo Finance

Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals stock hits 52-week high at 13.6 USD - Investing.com

Aurinia Pharmaceuticals stock hits 52-week high at 13.6 USD  Investing.com

Aurinia Pharmaceuticals stock hits 52-week high at 13.6 USD - Investing.com

Click here to get full coverage on at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025 - Business Wire

at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025  Business Wire

at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025 - Business Wire

Click here to get full coverage on Day 6 of Gains Streak for Aurinia Pharmaceuticals Stock with 32% Return (vs. 30% YTD) [8/5/2025] - Trefis

Day 6 of Gains Streak for Aurinia Pharmaceuticals Stock with 32% Return (vs. 30% YTD) [8/5/2025]  Trefis

Day 6 of Gains Streak for Aurinia Pharmaceuticals Stock with 32% Return (vs. 30% YTD) [8/5/2025] - Trefis

Click here to get full coverage on Aurinia Pharmaceuticals Boosts 2025 Sales Guidance Amid Strong Q3 Performance - TipRanks

Aurinia Pharmaceuticals Boosts 2025 Sales Guidance Amid Strong Q3 Performance  TipRanks

Aurinia Pharmaceuticals Boosts 2025 Sales Guidance Amid Strong Q3 Performance - TipRanks

Click here to get full coverage on Jefferies reiterates Hold rating on Aurinia Pharmaceuticals stock at $10 price target - Investing.com

Jefferies reiterates Hold rating on Aurinia Pharmaceuticals stock at $10 price target  Investing.com

Jefferies reiterates Hold rating on Aurinia Pharmaceuticals stock at $10 price target - Investing.com

Click here to get full coverage on Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200) - Business Wire

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)  Business Wire

Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200) - Business Wire

Click here to get full coverage on Aurinia Pharma director Tang buys $13.59m in shares - Investing.com

Aurinia Pharma director Tang buys $13.59m in shares  Investing.com

Aurinia Pharma director Tang buys $13.59m in shares - Investing.com

Click here to get full coverage on Aurinia Pharmaceuticals to Announce Q3 2025 Financial Results and Business Update - TipRanks

Aurinia Pharmaceuticals to Announce Q3 2025 Financial Results and Business Update  TipRanks

Aurinia Pharmaceuticals to Announce Q3 2025 Financial Results and Business Update - TipRanks

Click here to get full coverage on Aurinia Pharmaceuticals To Report Q3 Results, Provide Update On Recent Business Progress On November 4 - TradingView

Aurinia Pharmaceuticals To Report Q3 Results, Provide Update On Recent Business Progress On November 4  TradingView

Aurinia Pharmaceuticals To Report Q3 Results, Provide Update On Recent Business Progress On November 4 - TradingView

Click here to get full coverage on Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery - Stocktwits

Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery  Stocktwits

Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery - Stocktwits

Click here to get full coverage on Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - sharewise.com

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake?  sharewise.com

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - sharewise.com

Click here to get full coverage on Aurinia Pharmaceuticals stock hits 52-week high at 11.81 USD - Investing.com

Aurinia Pharmaceuticals stock hits 52-week high at 11.81 USD  Investing.com

Aurinia Pharmaceuticals stock hits 52-week high at 11.81 USD - Investing.com

Click here to get full coverage on Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView

Aurinia Pharmaceuticals Inc. SEC 10-Q Report  TradingView

Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView

Click here to get full coverage on Aurinia Pharmaceuticals Reports Strong Q3 2025 Growth and Raises Sales Guidance - TipRanks

Aurinia Pharmaceuticals Reports Strong Q3 2025 Growth and Raises Sales Guidance  TipRanks

Aurinia Pharmaceuticals Reports Strong Q3 2025 Growth and Raises Sales Guidance - TipRanks

Click here to get full coverage on H.C. Wainwright assumes coverage on Aurinia Pharmaceuticals stock with Buy rating - Investing.com

H.C. Wainwright assumes coverage on Aurinia Pharmaceuticals stock with Buy rating  Investing.com

H.C. Wainwright assumes coverage on Aurinia Pharmaceuticals stock with Buy rating - Investing.com

Click here to get full coverage on Aurinia to present new voclosporin data at rheumatology conferences - Investing.com

Aurinia to present new voclosporin data at rheumatology conferences  Investing.com

Aurinia to present new voclosporin data at rheumatology conferences - Investing.com

Click here to get full coverage on Aurinia Pharmaceuticals Reaffirms Confidence in LUPKYNIS After Retraction - TipRanks

Aurinia Pharmaceuticals Reaffirms Confidence in LUPKYNIS After Retraction  TipRanks

AUPH

Price Chart

Key Statistics

Technicals

About AUPH

Latest News

Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year? - Yahoo Finance

A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation Following Recent Share Price Gains - simplywall.st

New Analyst Forecast: $AUPH Given $16 Price Target - Quiver Quantitative

Advanced Charts

Top Gainers

Top Losers